Late development of antidesmoglein 1 antibodies in pemphigus vulgaris

Correlation with disease progression

S. Miyagawa, Masayuki Amagai, T. Iida, Y. Yamamoto, T. Nishikawa, T. Shirai

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

The coexistence of antidesmoglein 3 (Dsg3) and antidesmoglein 1 (Dsg1) autoantibodies is well described in patients with pemphigus vulgaris (PV); however, there is little evidence of sequential development of these two autoantibodies. Autoantibody responses to Dsg3 and Dsg1 were studied in seven PV patients over time by enzyme-linked immunosorbent assay, using baculovirus expressed recombinant fusion proteins. All patients had anti-Dsg3 IgG antibodies at presentation. Two patients developed anti-Dsg1 later in the course of the disease. The transition in autoantibody profile was associated with disease progression to generalized PV involving mucous membranes and skin in both patients; one patient initially presented with a predominantly mucosal phenotype, the other with herpetiform pemphigus-like features. These findings demonstrate that there is an extension of autoimmune response from anti-Dsg3 only to both anti-Dsg3 and anti-Dsg1 in some patients, which is associated with an alteration in clinical expression in PV.

Original languageEnglish
Pages (from-to)1084-1087
Number of pages4
JournalBritish Journal of Dermatology
Volume141
Issue number6
DOIs
Publication statusPublished - 1999

Fingerprint

Pemphigus
Disease Progression
Antibodies
Autoantibodies
Recombinant Fusion Proteins
Baculoviridae
Autoimmunity
Mucous Membrane
Enzyme-Linked Immunosorbent Assay
Phenotype
Skin

Keywords

  • Antidesmoglein 1 antibodies
  • Antidesmoglein 3 antibodies
  • Pemphigus vulgaris
  • Sequential development of antibodies

ASJC Scopus subject areas

  • Dermatology

Cite this

Late development of antidesmoglein 1 antibodies in pemphigus vulgaris : Correlation with disease progression. / Miyagawa, S.; Amagai, Masayuki; Iida, T.; Yamamoto, Y.; Nishikawa, T.; Shirai, T.

In: British Journal of Dermatology, Vol. 141, No. 6, 1999, p. 1084-1087.

Research output: Contribution to journalArticle

Miyagawa, S. ; Amagai, Masayuki ; Iida, T. ; Yamamoto, Y. ; Nishikawa, T. ; Shirai, T. / Late development of antidesmoglein 1 antibodies in pemphigus vulgaris : Correlation with disease progression. In: British Journal of Dermatology. 1999 ; Vol. 141, No. 6. pp. 1084-1087.
@article{43a160ef3baa40f09ef1ab5009a70724,
title = "Late development of antidesmoglein 1 antibodies in pemphigus vulgaris: Correlation with disease progression",
abstract = "The coexistence of antidesmoglein 3 (Dsg3) and antidesmoglein 1 (Dsg1) autoantibodies is well described in patients with pemphigus vulgaris (PV); however, there is little evidence of sequential development of these two autoantibodies. Autoantibody responses to Dsg3 and Dsg1 were studied in seven PV patients over time by enzyme-linked immunosorbent assay, using baculovirus expressed recombinant fusion proteins. All patients had anti-Dsg3 IgG antibodies at presentation. Two patients developed anti-Dsg1 later in the course of the disease. The transition in autoantibody profile was associated with disease progression to generalized PV involving mucous membranes and skin in both patients; one patient initially presented with a predominantly mucosal phenotype, the other with herpetiform pemphigus-like features. These findings demonstrate that there is an extension of autoimmune response from anti-Dsg3 only to both anti-Dsg3 and anti-Dsg1 in some patients, which is associated with an alteration in clinical expression in PV.",
keywords = "Antidesmoglein 1 antibodies, Antidesmoglein 3 antibodies, Pemphigus vulgaris, Sequential development of antibodies",
author = "S. Miyagawa and Masayuki Amagai and T. Iida and Y. Yamamoto and T. Nishikawa and T. Shirai",
year = "1999",
doi = "10.1046/j.1365-2133.1999.03209.x",
language = "English",
volume = "141",
pages = "1084--1087",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Late development of antidesmoglein 1 antibodies in pemphigus vulgaris

T2 - Correlation with disease progression

AU - Miyagawa, S.

AU - Amagai, Masayuki

AU - Iida, T.

AU - Yamamoto, Y.

AU - Nishikawa, T.

AU - Shirai, T.

PY - 1999

Y1 - 1999

N2 - The coexistence of antidesmoglein 3 (Dsg3) and antidesmoglein 1 (Dsg1) autoantibodies is well described in patients with pemphigus vulgaris (PV); however, there is little evidence of sequential development of these two autoantibodies. Autoantibody responses to Dsg3 and Dsg1 were studied in seven PV patients over time by enzyme-linked immunosorbent assay, using baculovirus expressed recombinant fusion proteins. All patients had anti-Dsg3 IgG antibodies at presentation. Two patients developed anti-Dsg1 later in the course of the disease. The transition in autoantibody profile was associated with disease progression to generalized PV involving mucous membranes and skin in both patients; one patient initially presented with a predominantly mucosal phenotype, the other with herpetiform pemphigus-like features. These findings demonstrate that there is an extension of autoimmune response from anti-Dsg3 only to both anti-Dsg3 and anti-Dsg1 in some patients, which is associated with an alteration in clinical expression in PV.

AB - The coexistence of antidesmoglein 3 (Dsg3) and antidesmoglein 1 (Dsg1) autoantibodies is well described in patients with pemphigus vulgaris (PV); however, there is little evidence of sequential development of these two autoantibodies. Autoantibody responses to Dsg3 and Dsg1 were studied in seven PV patients over time by enzyme-linked immunosorbent assay, using baculovirus expressed recombinant fusion proteins. All patients had anti-Dsg3 IgG antibodies at presentation. Two patients developed anti-Dsg1 later in the course of the disease. The transition in autoantibody profile was associated with disease progression to generalized PV involving mucous membranes and skin in both patients; one patient initially presented with a predominantly mucosal phenotype, the other with herpetiform pemphigus-like features. These findings demonstrate that there is an extension of autoimmune response from anti-Dsg3 only to both anti-Dsg3 and anti-Dsg1 in some patients, which is associated with an alteration in clinical expression in PV.

KW - Antidesmoglein 1 antibodies

KW - Antidesmoglein 3 antibodies

KW - Pemphigus vulgaris

KW - Sequential development of antibodies

UR - http://www.scopus.com/inward/record.url?scp=0033393732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033393732&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2133.1999.03209.x

DO - 10.1046/j.1365-2133.1999.03209.x

M3 - Article

VL - 141

SP - 1084

EP - 1087

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 6

ER -